Adaptability of prognostic prediction models for patients with acute coronary syndrome during the COVID-19 pandemic.

IF 4.1 Q1 HEALTH CARE SCIENCES & SERVICES BMJ Health & Care Informatics Pub Date : 2024-07-01 DOI:10.1136/bmjhci-2024-101074
Masahiro Nishi, Takeshi Nakamura, Kenji Yanishi, Satoaki Matoba
{"title":"Adaptability of prognostic prediction models for patients with acute coronary syndrome during the COVID-19 pandemic.","authors":"Masahiro Nishi, Takeshi Nakamura, Kenji Yanishi, Satoaki Matoba","doi":"10.1136/bmjhci-2024-101074","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The detrimental repercussions of the COVID-19 pandemic on the quality of care and clinical outcomes for patients with acute coronary syndrome (ACS) necessitate a rigorous re-evaluation of prognostic prediction models in the context of the pandemic environment. This study aimed to elucidate the adaptability of prediction models for 30-day mortality in patients with ACS during the pandemic periods.</p><p><strong>Methods: </strong>A total of 2041 consecutive patients with ACS were included from 32 institutions between December 2020 and April 2023. The dataset comprised patients who were admitted for ACS and underwent coronary angiography for the diagnosis during hospitalisation. The prediction accuracy of the Global Registry of Acute Coronary Events (GRACE) and a machine learning model, KOTOMI, was evaluated for 30-day mortality in patients with ST-elevation acute myocardial infarction (STEMI) and non-ST-elevation acute coronary syndrome (NSTE-ACS).</p><p><strong>Results: </strong>The area under the receiver operating characteristics curve (AUROC) was 0.85 (95% CI 0.81 to 0.89) in the GRACE and 0.87 (95% CI 0.82 to 0.91) in the KOTOMI for STEMI. The difference of 0.020 (95% CI -0.098-0.13) was not significant. For NSTE-ACS, the respective AUROCs were 0.82 (95% CI 0.73 to 0.91) in the GRACE and 0.83 (95% CI 0.74 to 0.91) in the KOTOMI, also demonstrating insignificant difference of 0.010 (95% CI -0.023 to 0.25). The prediction accuracy of both models had consistency in patients with STEMI and insignificant variation in patients with NSTE-ACS between the pandemic periods.</p><p><strong>Conclusions: </strong>The prediction models maintained high accuracy for 30-day mortality of patients with ACS even in the pandemic periods, despite marginal variation observed.</p>","PeriodicalId":9050,"journal":{"name":"BMJ Health & Care Informatics","volume":"31 1","pages":""},"PeriodicalIF":4.1000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11218009/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Health & Care Informatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjhci-2024-101074","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The detrimental repercussions of the COVID-19 pandemic on the quality of care and clinical outcomes for patients with acute coronary syndrome (ACS) necessitate a rigorous re-evaluation of prognostic prediction models in the context of the pandemic environment. This study aimed to elucidate the adaptability of prediction models for 30-day mortality in patients with ACS during the pandemic periods.

Methods: A total of 2041 consecutive patients with ACS were included from 32 institutions between December 2020 and April 2023. The dataset comprised patients who were admitted for ACS and underwent coronary angiography for the diagnosis during hospitalisation. The prediction accuracy of the Global Registry of Acute Coronary Events (GRACE) and a machine learning model, KOTOMI, was evaluated for 30-day mortality in patients with ST-elevation acute myocardial infarction (STEMI) and non-ST-elevation acute coronary syndrome (NSTE-ACS).

Results: The area under the receiver operating characteristics curve (AUROC) was 0.85 (95% CI 0.81 to 0.89) in the GRACE and 0.87 (95% CI 0.82 to 0.91) in the KOTOMI for STEMI. The difference of 0.020 (95% CI -0.098-0.13) was not significant. For NSTE-ACS, the respective AUROCs were 0.82 (95% CI 0.73 to 0.91) in the GRACE and 0.83 (95% CI 0.74 to 0.91) in the KOTOMI, also demonstrating insignificant difference of 0.010 (95% CI -0.023 to 0.25). The prediction accuracy of both models had consistency in patients with STEMI and insignificant variation in patients with NSTE-ACS between the pandemic periods.

Conclusions: The prediction models maintained high accuracy for 30-day mortality of patients with ACS even in the pandemic periods, despite marginal variation observed.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19 大流行期间急性冠状动脉综合征患者预后预测模型的适应性。
背景:COVID-19 大流行对急性冠状动脉综合征(ACS)患者的护理质量和临床结果造成了不利影响,因此有必要在大流行环境下对预后预测模型进行严格的重新评估。本研究旨在阐明大流行期间急性冠状动脉综合征患者 30 天死亡率预测模型的适应性:在 2020 年 12 月至 2023 年 4 月期间,32 家机构共纳入了 2041 名连续的 ACS 患者。数据集包括因 ACS 入院并在住院期间接受冠状动脉造影诊断的患者。评估了全球急性冠脉事件登记(GRACE)和机器学习模型KOTOMI对ST段抬高急性心肌梗死(STEMI)和非ST段抬高急性冠脉综合征(NSTE-ACS)患者30天死亡率的预测准确性:对于 STEMI,GRACE 和 KOTOMI 的接收者操作特征曲线下面积(AUROC)分别为 0.85(95% CI 0.81 至 0.89)和 0.87(95% CI 0.82 至 0.91)。0.020(95% CI -0.098-0.13)的差异并不显著。对于NSTE-ACS,GRACE和KOTOMI的AUROCs分别为0.82(95% CI 0.73至0.91)和0.83(95% CI 0.74至0.91),也显示出0.010(95% CI -0.023至0.25)的差异不显著。两种模型对 STEMI 患者的预测准确性具有一致性,而对 NSTE-ACS 患者的预测准确性在大流行期间差异不大:结论:即使在大流行期间,预测模型对 ACS 患者 30 天死亡率的预测也保持了较高的准确性,尽管观察到的差异很小。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
相关文献
Tumor-suppressive function and mechanism of miR-873-5p in glioblastoma: evidence based on bioinformatics analysis and experimental validation.
IF 5.2 3区 医学Aging-UsPub Date : 2023-06-28 DOI: 10.18632/aging.204800
Xiaobin Zhang, Fangkun Jing, Chen Guo, Xinning Li, Jianan Li, Guobiao Liang
来源期刊
CiteScore
6.10
自引率
4.90%
发文量
40
审稿时长
18 weeks
期刊最新文献
Artificial intelligence for predicting interstitial fibrosis and tubular atrophy using diagnostic ultrasound imaging and biomarkers. Data's big three: how learning health systems, artificial intelligence and predictive analytics are transforming healthcare. Biomarker and clinical data-based predictor tool (MAUXI) for ultrafiltration failure and cardiovascular outcome in peritoneal dialysis patients: a retrospective and longitudinal study. Benchmarking open-source large language models on Portuguese Revalida multiple-choice questions. Potential role of ChatGPT in simplifying and improving informed consent forms for vaccination: a pilot study conducted in Italy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1